Innovation and medicinegettyWe are on a bureaucratic trajectory where American leadership in approving innovative medicines may not be sustainable and…
Browsing: Edge
With the proposed funding cuts to the National Institutes of Health by the Trump administration, the biopharma industry is bracing…
The United States Biotechnology Sector at Risk of Losing Ground to China The biotechnology sector in the United States faces…
The National Institutes of Health (NIH) is currently facing significant workforce cuts, causing a wave of fear and confusion among…
The debate over Medicaid funding cuts in Washington has brought words to the forefront as a central battleground. Republican lawmakers…
The recent confusion surrounding federal funding under the Trump administration has left many in the biotech and pharma industries uncertain…
ZHANGJIAKOU, CHINA – MARCH 07: Mike Schultz of Team United States and Zhongwei Wu of Team China … [+] compete…
